External Validation of the PRI-MUS Scoring System: A Secondary Analysis of the OPTIMUM Randomized Controlled Trial
Alon Lazarovich(University of Alberta), Adam Kinnaird(University of Alberta), Christopher Fung(University of Alberta), Arvin K. George(Johns Hopkins University), Sangeet Ghai(University Health Network), Karsten Günzel(Medizinische Hochschule Brandenburg Theodor Fontane), Niklas Harland(STZ eyetrial), Petr Macek(Institute Mutualiste Montsouris), Andreas Gusenleitner(Krankenhaus der Elisabethinen), Wayne Brisbane(University of California, Los Angeles), Ferdinand Luger(Krankenhaus der Elisabethinen), Joseph Brito(Dana-Farber Cancer Institute), H. Toledano, Melis Güer(Optimum Therapeutics (United States)), Peter Incze(Oakville-Trafalgar Memorial Hospital), Wendy Tu(University of Alberta), Joseph Renzulli(Yale University), Moisés Rodriguez-Socarrás(Clínica Rementería), Mohammed Salah Ouertani(Centre Hospitalier Interrégional Edith Cavell), Robert Jansen, Martin Schostak(Klinikum Magdeburg), Julian P Struck(Universitätsklinikum Brandenburg an der Havel), L Felipe Urdaneta-Salegui(Clinic IMQ Zorrotzaurre), Laurence Klotz(Sunnybrook Health Science Centre), Christian P Pavlovich(Johns Hopkins University), Neal D Shore(Carolina Urologic Research Center), J.G. Pereira(Clinic IMQ Zorrotzaurre), Giovanni Lughezzani(Humanitas University), Hannes Cash(Royal Free London NHS Foundation Trust)
Cited by 0
Related Papers
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial
|Clinical Cancer Research|2017|635
An overview of kidney stone imaging techniques
|Nature Reviews Urology|2016|389
Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients
|Science Translational Medicine|2017|311
Targeted Prostate Biopsy: Umbra, Penumbra, and Value of Perilesional Sampling
|European Urology|2022|169